VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
IHiHuman Inc.
$1.38$15M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

IH logoiHuman Inc.(IH)Earnings, Financials & Key Ratios

IH•NYSE
1.0× P/E·Price updated Jun 19, 2026
SectorConsumer DefensiveIndustryEducation & TrainingSub-IndustryConsumer Learning Platforms and Apps
AboutiHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. It also provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. The company was founded in 1996 and is based in Beijing, the People's Republic of China.Show more
  • Revenue$922M-9.4%
  • EBITDA$86M-50.1%
  • Net Income$99M-45.5%
  • EPS (Diluted)9.00-45.5%
  • Gross Margin69.42%-2.0%
  • EBITDA Margin9.28%-44.9%
  • Operating Margin7.8%-50.3%
  • Net Margin10.69%-39.8%
  • ROE10.28%-50.9%

IH Key Insights

iHuman Inc. (IH) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong 5Y sales CAGR of 33.4%
  • ✓Good 3Y average ROE of 15.7%
  • ✓Trading at only 0.1x book value

✗Weaknesses

  • ✗Weak momentum: RS Rating 12 (bottom 12%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when IH posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

IH Price & Volume

iHuman Inc. (IH) stock price & volume — 10-year historical chart

Loading chart...

IH Growth Metrics

iHuman Inc. (IH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years33.36%
3 Years-0.8%
TTM-8.25%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-16.74%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-15.91%

Return on Capital

10 Years3.87%
5 Years3.87%
3 Years13.99%
Last Year7.44%

IH Peer Comparison

iHuman Inc. (IH) competitors in Consumer Learning Platforms and Apps — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
GOTU logoGOTUGaotu Techedu Inc.Direct Competitor598.53M1.65-13.2834.99%-5.26%-20.84%0.47
COE logoCOE51Talk Online Education GroupDirect Competitor1.55M15.62-0.0989.09%-16.46%
TAL logoTALTAL Education GroupProduct Competitor621.37M9.197.2951.22%6.45%4.72%0.09
EDU logoEDUNew Oriental Education & Technology Group Inc.Product Competitor7.16B45.0219.5713.6%7.37%9.09%0.20
DAO logoDAOYoudao, Inc.Product Competitor1.42B12.0590.535.03%1.82%
FEDU logoFEDUFour Seasons Education (Cayman) Inc.Product Competitor2.09M9.8617.55100.15%0.32%0.16%0.19
BILI logoBILIBilibili Inc.Supply Chain7.21B17.2044.9013.1%0.75%1.56%0.62
BIDU logoBIDUBaidu, Inc.Supply Chain38.01B111.7664.26-3.04%3.48%0.21%0.34

Compare IH vs Peers

iHuman Inc. (IH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs GOTU

Most directly comparable listed peer for IH.

Scale Benchmark

vs NTES

Larger-name benchmark to compare IH against a more recognizable public peer.

Peer Set

Compare Top 5

vs GOTU, COE, TAL, EDU

IH Income Statement

iHuman Inc. (IH) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue
131.87M218.66M531.91M944.72M985.52M1.02B922.2M882.69M
Revenue Growth %
-65.82%143.27%77.61%4.32%3.31%-9.42%-8.25%
Cost of Goods Sold
65.85M84.16M166.47M284.1M294.34M296.87M282.05M282.86M
COGS % of Revenue
49.94%38.49%31.3%30.07%29.87%29.16%30.58%-
Gross Profit
66.01M▲ 0%
134.49M▲ 103.7%
365.44M▲ 171.7%
660.62M▲ 80.8%
691.17M▲ 4.6%
721.27M▲ 4.4%
640.15M▼ 11.2%
599.83M▲ 0%
Gross Margin %
50.06%61.51%68.7%69.93%70.13%70.84%69.42%67.95%
Gross Profit Growth %
-103.74%171.72%80.77%4.62%4.35%-11.25%-
Operating Expenses
88.08M413.3M409.89M714.87M579.59M561.38M568.24M523.13M
OpEx % of Revenue
66.79%189.02%77.06%75.67%58.81%55.14%61.62%-
Selling, General & Admin
35.97M243.15M210.38M299.54M266.11M303.84M320.48M292.3M
SG&A % of Revenue
27.28%111.2%39.55%31.71%27%29.84%34.75%-
Research & Development
52.1M170.16M199.51M415.33M313.48M257.55M247.76M230.83M
R&D % of Revenue
39.51%77.82%37.51%43.96%31.81%25.3%26.87%-
Other Operating Expenses
00000000
Operating Income
-22.06M▲ 0%
-278.81M▼ 1163.7%
-44.45M▲ 84.1%
-54.25M▼ 22.0%
111.58M▲ 305.7%
159.89M▲ 43.3%
71.91M▼ 55.0%
76.7M▲ 0%
Operating Margin %
-16.73%-127.51%-8.36%-5.74%11.32%15.7%7.8%8.69%
Operating Income Growth %
--1163.7%84.06%-22.04%305.69%43.29%-55.02%-
EBITDA
-21.7M-278.21M-41.64M-47.83M122.41M171.58M85.57M76.7M
EBITDA Margin %
-16.45%-127.24%-7.83%-5.06%12.42%16.85%9.28%8.69%
EBITDA Growth %
--1182.21%85.03%-14.87%355.94%40.16%-50.13%-30.31%
D&A (Non-Cash Add-back)
365K597K2.81M6.42M10.83M11.69M13.66M0
EBIT
-22.06M-278.81M-44.45M-54.25M111.58M159.89M71.91M76.7M
Net Interest Income
0009.44M12.19M28.54M00
Interest Income
0009.44M12.19M28.54M00
Interest Expense
00000000
Other Income/Expense
6.07M4.58M7.44M17.05M21.19M42.69M38.69M43.04M
Pretax Income
-15.99M▲ 0%
-274.23M▼ 1614.6%
-37.01M▲ 86.5%
-37.2M▼ 0.5%
132.77M▲ 457.0%
202.57M▲ 52.6%
110.6M▼ 45.4%
119.75M▲ 0%
Pretax Margin %
-12.13%-125.42%-6.96%-3.94%13.47%19.9%11.99%13.57%
Income Tax
1.61M1.36M466K-145K22.95M21.67M12.01M9.71M
Effective Tax Rate %
-10.07%-0.5%-1.26%0.39%17.29%10.7%10.86%8.11%
Net Income
-17.6M▲ 0%
-275.6M▼ 1465.5%
-37.48M▲ 86.4%
-37.05M▲ 1.1%
109.82M▲ 396.4%
180.91M▲ 64.7%
98.59M▼ 45.5%
110.03M▲ 0%
Net Margin %
-13.35%-126.04%-7.05%-3.92%11.14%17.77%10.69%12.47%
Net Income Growth %
--1465.54%86.4%1.13%396.4%64.73%-45.5%-16.74%
Net Income (Continuing)
-17.6M-275.6M-37.48M-37.05M109.82M180.91M98.59M110.03M
Discontinued Operations
00000000
Minority Interest
00000000
EPS (Diluted)
-1.72▲ 0%
-25.85▼ 1402.9%
-5.35▲ 79.3%
-3.50▲ 34.6%
10.15▲ 390.0%
16.50▲ 62.6%
9.00▼ 45.5%
10.29▲ 0%
EPS Growth %
--1402.91%79.3%34.58%390%62.56%-45.45%-15.91%
EPS (Basic)
-1.72-25.85-5.35-3.4510.3017.159.40-
Diluted Shares Outstanding
10.66M10.66M9.05M10.67M10.81M10.95M10.85M10.7M
Basic Shares Outstanding
10.66M10.66M9.05M10.67M10.66M10.56M10.48M10.28M
Dividend Payout Ratio
------35.77%-

IH Balance Sheet

iHuman Inc. (IH) balance sheet — assets, liabilities & shareholders' equity

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets
57.33M163.06M1.02B1.02B1.25B1.38B1.34B1.26B
Cash & Short-Term Investments
6.12M104.88M861.68M855.36M1.05B1.21B1.17B1.1B
Cash Only
6.12M104.88M861.68M855.36M1.05B1.21B1.12B605.14M
Short-Term Investments
00000045.46M495M
Accounts Receivable
13.62M20.98M78.29M58.98M81.9M62.64M54.08M57.77M
Days Sales Outstanding
37.7135.0353.7222.7930.3322.4621.424.95
Inventory
29.63M20.66M16.87M28.05M19.13M16.52M23.48M20.66M
Days Inventory Outstanding
164.2289.623736.0423.7220.3130.3825.79
Other Current Assets
7.64M14.09M64.62M72.85M102.77M72.5M69.2M85.22M
Total Non-Current Assets
1.27M5.25M25.48M85.64M79.61M68.06M83.82M71.29M
Property, Plant & Equipment
660K2.49M12.91M50.52M21.99M9.82M18.36M14.93M
Fixed Asset Turnover
199.80x87.92x41.20x18.70x44.82x103.71x50.23x62.33x
Goodwill
00000000
Intangible Assets
136K103K11.79M27.29M24.87M23.25M16.43M14.92M
Long-Term Investments
000026.33M26.33M26.33M105.33M
Other Non-Current Assets
478K2.66M784K7.83M6.42M8.66M22.7M15.11M
Total Assets
58.6M▲ 0%
168.31M▲ 187.2%
1.05B▲ 522.0%
1.1B▲ 5.2%
1.33B▲ 21.1%
1.45B▲ 8.8%
1.42B▼ 2.1%
1.34B▲ 0%
Asset Turnover
2.25x1.30x0.51x0.86x0.74x0.70x0.65x0.64x
Asset Growth %
-187.23%522.02%5.15%21.12%8.78%-2.13%-3.71%
Total Current Liabilities
122.33M182.76M399.22M482.93M561.05M490.76M447.54M355.69M
Accounts Payable
13.13M10.3M21.55M30.54M24.21M22.14M30.23M21.2M
Days Payables Outstanding
72.844.6847.2539.2330.0227.2239.1232.76
Short-Term Debt
61.82M0000000
Deferred Revenue (Current)
28.15M71.83M268.61M302.98M379.06M0283.25M791.18M
Other Current Liabilities
29.94M70.96M3.34M7.36M5.17M356.31M5.82M0
Current Ratio
0.47x0.89x2.56x2.10x2.23x2.82x2.98x3.55x
Quick Ratio
0.23x0.78x2.52x2.04x2.20x2.78x2.93x3.49x
Cash Conversion Cycle
129.1379.9743.4619.624.0315.5512.6617.98
Total Non-Current Liabilities
005.07M9.58M2.89M1.93M11.25M10.01M
Long-Term Debt
00000000
Capital Lease Obligations
005.07M9.58M2.89M1.93M11.25M32.58M
Deferred Tax Liabilities
00000000
Other Non-Current Liabilities
00000000
Total Liabilities
122.33M182.76M404.29M492.51M563.95M492.69M458.8M365.7M
Total Debt
61.82M06.61M34.25M9.02M3.86M14.91M12.28M
Net Debt
55.7M-104.88M-855.07M-821.12M-1.04B-1.21B-1.11B-592.86M
Debt / Equity
--0.01x0.06x0.01x0.00x0.02x0.01x
Debt / EBITDA
----0.07x0.02x0.17x0.16x
Net Debt / EBITDA
-----8.50x-7.05x-12.95x-7.73x
Interest Coverage
--------
Total Equity
-63.73M▲ 0%
-14.45M▲ 77.3%
642.65M▲ 4547.7%
608.37M▼ 5.3%
769.45M▲ 26.5%
957.8M▲ 24.5%
960.85M▲ 0.3%
969.39M▲ 0%
Equity Growth %
-77.33%4547.73%-5.33%26.48%24.48%0.32%13%
Book Value per Share
-5.98-1.3570.9857.0471.1987.4788.5790.63
Total Shareholders' Equity
-63.73M-14.45M642.65M608.37M769.45M957.8M960.85M969.39M
Common Stock
111K158K184K185K185K185K185K185K
Retained Earnings
-72.9M-348.5M-385.97M-423.02M-321.17M-140.46M-42.1M16.3M
Treasury Stock
000-164K-7.12M-16.66M-26.3M-38.12M
Accumulated OCI
-532K0-21.86M-34.68M18.46M26.12M32.4M30.85M
Minority Interest
00000000

IH Cash Flow Statement

iHuman Inc. (IH) cash flow — operating, investing & free cash flow history

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations
-4.5M42.63M222.99M38.21M1.29B172.12M58.55M0
Operating CF Margin %
-3.42%19.5%41.92%4.04%131.03%16.91%6.35%-
Operating CF Growth %
-1046.43%423.11%-82.86%3279.3%-86.67%-65.99%0%
Net Income
-17.6M-275.6M-37.48M-37.05M752.48M180.91M98.59M110.03M
Depreciation & Amortization
365K597K2.81M6.42M74.22M11.69M13.66M0
Stock-Based Compensation
0270.54M79.89M15.18M89.38M9.44M2.82M1.49M
Deferred Taxes
001.43M1.67M0000
Other Non-Cash Items
194K249K11.3M21.75M197.34M-52.12M2.01M-111.53M
Working Capital Changes
12.54M46.84M165.03M30.25M177.95M22.21M-58.54M0
Change in Receivables
-12.41M-6.63M-57.69M21.61M-195.34M18.29M8.98M0
Change in Inventory
4.62M8.85M2.2M-12.62M46.05M3.03M-7.24M0
Change in Payables
-1.96M-2.83M11.25M8.98M-43.37M-2.08M8.05M0
Cash from Investing
-529K-2.39M-15.91M-31.95M-225.03M-6.51M-52.76M0
Capital Expenditures
-529K-2.39M-15.91M-32.28M-45.14M-6.51M-7.45M0
CapEx % of Revenue
0.4%1.09%2.99%3.42%4.58%0.64%0.81%0%
Acquisitions
00000000
Investments
--------
Other Investing
000332K541.31K000
Cash from Financing
10.31M58.52M571.96M410K-47.66M-9.45M-102.28M0
Debt Issued (Net)
00000000
Equity Issued (Net)
0120M629.55M-164K-6.96M-9.54M-9.63M0
Dividends Paid
-10.89M-3.1M-66M000-35.27M0
Share Repurchases
000-164K-6.96M-9.54M-9.63M0
Other Financing
21.2M-58.38M8.4M574K-40.7M94K-57.38M0
Net Change in Cash
5.28M▲ 0%
98.76M▲ 1770.1%
756.8M▲ 666.3%
-6.32M▼ 100.8%
1.33B▲ 21202.0%
163.77M▼ 87.7%
-90.47M▼ 155.2%
0▲ 0%
Free Cash Flow
-5.03M▲ 0%
40.24M▲ 899.4%
207.08M▲ 414.7%
5.93M▼ 97.1%
1.25B▲ 20912.1%
165.61M▼ 86.7%
51.1M▼ 69.1%
0▲ 0%
FCF Margin %
-3.82%18.4%38.93%0.63%126.45%16.27%5.54%0%
FCF Growth %
-899.44%414.66%-97.14%20912.06%-86.71%-69.15%-
FCF per Share
-0.473.7722.870.56115.3015.124.710.00
FCF Conversion (FCF/Net Income)
0.26x-0.15x-5.95x-1.03x11.76x0.95x0.59x0.00x
Interest Paid
00000000
Taxes Paid
0015K459K8.36M23.28M21.8M0

IH Key Ratios

iHuman Inc. (IH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201920202021202220232024TTM
Return on Equity (ROE)
--11.93%-5.92%15.94%20.95%10.28%11.59%
Return on Invested Capital (ROIC)
------67.24%
Gross Margin
61.51%68.7%69.93%70.13%70.84%69.42%67.95%
Net Margin
-126.04%-7.05%-3.92%11.14%17.77%10.69%12.47%
Debt / Equity
-0.01x0.06x0.01x0.00x0.02x0.01x
FCF Conversion
-0.15x-5.95x-1.03x11.76x0.95x0.59x0.00x
Revenue Growth
65.82%143.27%77.61%4.32%3.31%-9.42%-8.25%
Related:IH Dividend History·IH Revenue History·IH Price History·IH P/E History·IH Financial Ratios·IH Institutional Holders

IH Frequently Asked Questions

iHuman Inc. (IH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

iHuman Inc. (IH) reported $882.7M in revenue for fiscal year 2024. This represents a 569% increase from $131.9M in 2018.

iHuman Inc. (IH) saw revenue decline by 9.4% over the past year.

Yes, iHuman Inc. (IH) is profitable, generating $110.0M in net income for fiscal year 2024 (10.7% net margin).

Dividend & Returns

Yes, iHuman Inc. (IH) pays a dividend with a yield of 34.87%. This makes it attractive for income-focused investors.

iHuman Inc. (IH) has a return on equity (ROE) of 10.3%. This is reasonable for most industries.

iHuman Inc. (IH) generated $51.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in IH back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →

How much would $100/month in IH be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →